Lyra Therapeutics Inc. (LYRA): Price and Financial Metrics
LYRA Price/Volume Stats
| Current price | $0.10 | 52-week high | $5.65 |
| Prev. close | $0.11 | 52-week low | $0.08 |
| Day low | $0.10 | Volume | 1,417,349 |
| Day high | $0.11 | Avg. volume | 1,212,166 |
| 50-day MA | $0.15 | Dividend yield | N/A |
| 200-day MA | $0.22 | Market Cap | 6.56M |
LYRA Stock Price Chart Interactive Chart >
Lyra Therapeutics Inc. (LYRA) Company Bio
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer and is headquartered in Watertown, MA.
LYRA Price Returns
| 1-mo | -28.01% |
| 3-mo | -45.33% |
| 6-mo | -63.32% |
| 1-year | -97.88% |
| 3-year | -98.23% |
| 5-year | N/A |
| YTD | -51.55% |
| 2024 | -96.06% |
| 2023 | 66.88% |
| 2022 | -27.98% |
| 2021 | -61.75% |
| 2020 | N/A |
Loading social stream, please wait...